Youth Diabetes Study: Closed-Loop Therapy's Dual Impact

Hybrid closed-loop insulin therapy reduces hypoglycemic coma risk and improves glycemic control but raises diabetic ketoacidosis risk in young patients with type 1 diabetes, a large population-based study finds.